Literature DB >> 17101657

Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia.

Juliane Bubeck Wardenburg1, Ravi J Patel, Olaf Schneewind.   

Abstract

A model of Staphylococcus aureus-induced pneumonia in adult, immunocompetent C57BL/6J mice is described. This model closely mimics the clinical and pathological features of pneumonia in human patients. Using this system, we defined a role for S. aureus strain Newman surface proteins and secreted exotoxins in pneumonia-related mortality.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17101657      PMCID： PMC1828520          DOI： 10.1128/IAI.01313-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  34 in total

1.  An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis.

Authors:  Sarkis K Mazmanian; Hung Ton-That; Kenneth Su; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 2.  Autoinduction and signal transduction in the regulation of staphylococcal virulence.

Authors:  Richard P Novick
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Factors affecting the course and severity of transnasally induced Staphylococcus aureus pneumonia in mice.

Authors:  Kazuhiro Kimura; Shuichi Miyazaki; Kazuhiro Tateda; Tetsuya Matsumoto; Shirou Tsujimoto; Keizo Yamaguchi
Journal:  J Med Microbiol       Date:  1999-11       Impact factor: 2.472

5.  Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung.

Authors:  Geoffrey Heyer; Shahryar Saba; Robert Adamo; William Rush; Grace Soong; Ambrose Cheung; Alice Prince
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT.

Authors:  S Narita; J Kaneko; J Chiba; Y Piémont; S Jarraud; J Etienne; Y Kamio
Journal:  Gene       Date:  2001-05-02       Impact factor: 3.688

7.  [Severe staphylococcal pneumonia in children].

Authors:  Y Gillet; B Issartel; P Vanhems; G Lina; F Vandenesch; J Etienne; D Floret
Journal:  Arch Pediatr       Date:  2001-09       Impact factor: 1.180

8.  Prophages of Staphylococcus aureus Newman and their contribution to virulence.

Authors:  Taeok Bae; Tadashi Baba; Keiichi Hiramatsu; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2006-11       Impact factor: 3.501

9.  Passage of heme-iron across the envelope of Staphylococcus aureus.

Authors:  Sarkis K Mazmanian; Eric P Skaar; Andrew H Gaspar; Munir Humayun; Piotr Gornicki; Joanna Jelenska; Andrzej Joachmiak; Dominique M Missiakas; Olaf Schneewind
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

Review 10.  Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.

Authors:  Tomas Maira-Litran; Andrea Kropec; Donald Goldmann; Gerald B Pier
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641
View more
  188 in total

1.  Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Pauline Yoong; Gerald B Pier
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Authors:  Batu K Sharma-Kuinkel; Yuling Wu; David E Tabor; Hoyin Mok; Bret R Sellman; Amy Jenkins; Li Yu; Hasan S Jafri; Thomas H Rude; Felicia Ruffin; Wiley A Schell; Lawrence P Park; Qin Yan; Joshua T Thaden; Julia A Messina; Vance G Fowler; Mark T Esser
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 3.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

Review 4.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

5.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

Review 6.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

7.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

8.  Statins enhance formation of phagocyte extracellular traps.

Authors:  Ohn A Chow; Maren von Köckritz-Blickwede; A Taylor Bright; Mary E Hensler; Annelies S Zinkernagel; Anna L Cogen; Richard L Gallo; Marc Monestier; Yanming Wang; Christopher K Glass; Victor Nizet
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

9.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.

Authors:  Nuno Cerca; Kimberly K Jefferson; Tomas Maira-Litrán; Danielle B Pier; Casie Kelly-Quintos; Donald A Goldmann; Joana Azeredo; Gerald B Pier
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.